Robert Olstein Olstein Capital Management
Robert Olstein is the founder of Olstein Capital Management and a long-time advocate of forensic accounting and quality-of-earnings analysis in equity investing. His process looks beyond headline multiples to assess earnings sustainability and balance-sheet risk. Olstein’s work is frequently referenced by investors who prioritize accounting diligence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Generac Holdings
GNRC
|
+$4.87M |
| 2 |
Medtronic
MDT
|
+$4.4M |
| 3 |
Zimmer Biomet
ZBH
|
+$4.12M |
| 4 |
Mastercard
MA
|
+$3.98M |
| 5 |
Visa
V
|
+$3.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar Tree
DLTR
|
+$7.04M |
| 2 |
Lowe's Companies
LOW
|
+$5.48M |
| 3 |
CVS Health
CVS
|
+$4.71M |
| 4 |
WCC
WESCO International
WCC
|
+$4.32M |
| 5 |
Equifax
EFX
|
+$4.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 18.47% |
| 2 | Consumer Discretionary | 16.88% |
| 3 | Financials | 15.92% |
| 4 | Healthcare | 15.23% |
| 5 | Technology | 13.24% |
Similar funds
Robert Olstein's Q4 2021 Portfolio in Review
As of Q4 2021, Robert Olstein held 108 positions worth $838M, up 2.7% from $816M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Robert Olstein's Q4 2021 filing shows 51 increased, 38 reduced and 6 closed positions. The largest sale was Dollar Tree, an estimated $7.04M.
By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Robert Olstein added most to Generac Holdings in Q4 2021, an estimated $4.87M increase.
- Robert Olstein's biggest Q4 2021 reduction was Dollar Tree, cutting an estimated $7.04M.
- Robert Olstein fully exited Lowe's Companies in Q4 2021, selling an estimated $5.48M.
- Robert Olstein's ten largest holdings make up 18% of its $838M portfolio in Q4 2021.
- Robert Olstein opened 0 new positions and closed 6 in Q4 2021.
- Robert Olstein's portfolio value rose 2.7% quarter-over-quarter to $838M.
Based on Olstein Capital Management's 13F filing for Q4 2021, filed 27 Jan 2022.